Roger M. Nitsch

Founder, President and CEO

Neurimmune

Professor Roger M. Nitsch is the President and CEO of Neurimmune, a Swiss biopharmaceutical company focussing on the development of antibody-based treatments for neurodegenerative diseases. He serves as a part-time Professor at the Institute of Regenerative Medicine at the University of Zurich, is an Executive Organizer of the International Conferences on Alzheimer’s and Parkinson’s Diseases (AD/PD), a board member of several biotechnology companies, as well as an advisor on the BB Pureos VC fund. Prior to his position at Neurimmune, he served at the University of Zurich, and held research positions at M.I.T. and MGH / Harvard Medical School, Boston, was a Group Leader at the Center for Molecular Neurobiology at the University of Hamburg, Germany. He was a fellow at the Max-Planck Institute for Medical Research in Heidelberg, received an MD from University of Heidelberg Medical School followed by Habilitation in Neurobiochemistry at University of Heidelberg, Germany.